Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Heparin Sodium

The articles shown below are all about the Heparin Sodium, through these related articles, you can get relevant information, notes in use, or latest trends about the Heparin Sodium. We hope these news will give you the help you need. And if these Heparin Sodium articles can't solve your needs, you can contact us for relevant information.
  • Heparin Market: A Comprehensive Guide to Sources, Types, and Clinical Applications

    Heparin Market: A Comprehensive Guide to Sources, Types, and Clinical Applications

    2025-01-09

    Heparin is one of the oldest biological drugs used in treating thrombosis and hemostasis. It is a naturally occurring polysaccharide in the glycosaminoglycan (GAG) family, found primarily in mast cells. Read More
  • Drug Patent & Exclusivity Expiration Report - Week of Oct 28 2024

    Drug Patent & Exclusivity Expiration Report - Week of Oct 28 2024

    2024-10-28

    This week, there are 6 drugs in the patent and exclusivity list. They are: - ALEXZA PHARMACEUTICALS INC's ADASUVE, containing active ingredient LOXAPINE - ASTRAZENECA PHARMACEUTICALS LP's BRILINTA, containing active ingredient TICAGRELOR - CORMEDIX INC's DEFENCATH, containing active ingredient HEPARIN SODIUM; TAUROLIDINE - ABBVIE INC's VUITY, containing active ingredient PILOCARPINE HYDROCHLORIDE - SANOFI AVENTIS US LLC's AUBAGIO, containing active ingredient TERIFLUNOMIDE - ASTRAZENECA UK LTD's CALQUENCE, containing active ingredient ACALABRUTINIB Read More